As of close of business last night, Tandem Diabetes Care Inc.’s stock clocked out at 53.33, down -2.47% from its previous closing price of $54.68. In other words, the price has decreased by $-1.35 from its previous closing price. On the day, 1285395 shares were traded. TNDM reached its highest trading level at $54.84 during the session, while it also had its lowest trading level at $52.97.
To gain a deeper understanding of TNDM’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 5.52 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 68.92. For the most recent quarter (mrq), Quick Ratio is recorded 5.40 and its Current Ratio is at 6.00. In the meantime, Its Debt-to-Equity ratio is 0.63 whereas as Long-Term Debt/Eq ratio is at 0.63.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Wells Fargo on August 09, 2022, Downgraded its rating to Underweight and sets its target price to $49 from $82 previously.
Wells Fargo Upgraded its Equal Weight to Overweight on January 19, 2022, whereas the target price for the stock was revised from $137 to $160.
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jun 08 when BERGER DAVID B sold 10,097 shares for $65.02 per share. The transaction valued at 656,515 led to the insider holds 2,457 shares of the business.
BLICKENSTAFF KIM D sold 10,762 shares of TNDM for $999,897 on May 17. The Director now owns 205,190 shares after completing the transaction at $92.91 per share. On May 09, another insider, Sheridan John F, who serves as the PRESIDENT & CEO of the company, bought 2,500 shares for $69.90 each. As a result, the insider paid 174,750 and bolstered with 10,058 shares of the company.
For the stock, the TTM Price-to-Sale (P/S) ratio is 4.58 while its Price-to-Book (P/B) ratio in mrq is 7.60.
Stock Price History:
Over the past 52 weeks, TNDM has reached a high of $155.86, while it has fallen to a 52-week low of $42.90. The 50-Day Moving Average of the stock is 55.15, while the 200-Day Moving Average is calculated to be 91.60.
It appears that TNDM traded 1.05M shares on average per day over the past three months and 1.95M shares per day over the past ten days. A total of 64.08M shares are outstanding, with a floating share count of 62.91M. Insiders hold about 0.10% of the company’s shares, while institutions hold 99.70% stake in the company. Shares short for TNDM as of Jul 14, 2022 were 4.5M with a Short Ratio of 4.03, compared to 3.9M on Jun 14, 2022. Therefore, it implies a Short% of Shares Outstanding of 7.03% and a Short% of Float of 7.87%.
As of right now, 11 analysts gave their recommendation on the stock of the company. On average, analysts expect EPS of $0.02 for the current quarter, with a high estimate of $0.17 and a low estimate of $-0.04, while EPS last year was $0.06. The consensus estimate for the next quarter is $0.17, with high estimates of $0.25 and low estimates of $0.11.
Analysts are recommending an EPS of between $0.66 and $0.2 for the fiscal current year, implying an average EPS of $0.37. EPS for the following year is $0.99, with 10 analysts recommending between $1.38 and $0.76.
A total of 12 analysts have provided revenue estimates for TNDM’s current fiscal year. The highest revenue estimate was $863M, while the lowest revenue estimate was $850M, resulting in an average revenue estimate of $857.12M. In the same quarter a year ago, actual revenue was $702.8M, up 22.00% from the average estimate. Based on 11 analysts’ estimates, the company’s revenue will be $1.04B in the next fiscal year. The high estimate is $1.08B and the low estimate is $1B. The average revenue growth estimate for next year is up 20.80% from the average revenue estimate for this year.